Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Panacos Pharmaceuticals, a biotechnology company, has announced that the company's chief medical officer, Scott McCallister, and the vice president of manufacturing operations, John Richards, will leave the company on February 13, 2009.
Subscribe to our email newsletter
These positions were eliminated after Panacos sold bevirimat, and the company has refocused its efforts on its early stage programs. Dr McCallister has served in this capacity since October 2006, and Dr Richards joined the company in February 2006.
Alan Dunton, president and CEO of Panacos, said: “I have tremendous respect for Scott and John and their devotion to Panacos and bevirimat. As a practicing clinician on the front lines, Scott knows better than most the need to bring new products to the market that improve the lives of people living with HIV.
“John and his team solved one of the major issues for bevirimat, the ability to create a viable tablet formulation, which was a huge advance in the development of this critical product for HIV. We know Scott and John will be invaluable to their colleagues at their next endeavors.”